5Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipidlowering therapy on plaque volume and composition in patients with coronary artery disease[J]. Circulation, 2001, 104(4): 387 - 392.
6Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques : implications for plaque stabilization [ J ]. Circulation,2001,103(7) : 926 - 933.
7Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy[J]. J Am Coil Cardiol, 2003, 42(4): 680- 686.
8Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival [ J]. JAMA, 2001,285:430 - 436.
9Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndrome: the GRACE study[J]. Ann Intern Med, 2004,140:857- 866.
10Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastain on early recurrent ischemic events in acute ccoronary syndromes- the MIRACLE study. Arandomized controlled trial[J]. JAMA, 2001,285:1711- 1718.
8Puccetti L,Cian F,Auteri A. Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study [ J ]. Atherosclerosis,2010,211 ( 1 ) :28.
9Julia HC, Carol C. Individualising the risks of statins in men and women in England and Wales : population-based cohort study [ J ]. Heart, 2010, 96(12) :939-947.
10Bruckert E, Hayem G, Dejager S, et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-the PRIMO study [ J ]. Cardiovasc Drugs Ther,2005,19 ( 6 ) :403-414.
